๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma

โœ Scribed by Meletios A. Dimopoulos; Donna Weber; Kay B. Delasalle; Raymond Alexanian


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
392 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Combined therapy consisting of intraarte
โœ Young-Hwa Chung; Il Han Song; Byung-Cheol Song; Geun Chan Lee; Moon Soo Koh; Hyu ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 1 views

## BACKGROUND. Hepatocellular carcinoma (HCC) patients with major vascular involvement or extrahepatic metastasis are not good candidates for surgery or transarterial chemoembolization (TACE). In this study, the authors evaluated the efficacy of combined therapy with intraarterial cisplatin infusio

Prognostic significance of the S-phase f
โœ Trendle, M.C.; Leong, T.; Kyle, R.A.; Katzmann, J.A.; Oken, M.M.; Kay, N.E.; Van ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 57 KB ๐Ÿ‘ 2 views

The bone marrow plasma cell labeling index (PCLI) as measured by bromodeoxyuridine uptake is a well-established independent prognostic factor for patients with newly diagnosed multiple myeloma, but the test is not easily done in most laboratories. The purpose of this study was to determine if the pr